Listen in as a doctor and a person with diabetes chat about new diabetes science. Cohosts Neil S. Skolnik, MD, professor of family and consumer medicine at Temple University School of Medicine and associate director of the family medicine residency program at Abington Memorial Hospital, and Kelly Rawlings, PWD, editorial director of Diabetes Forecast magazine, discuss highlights from the American Diabetes Association's professional scientific journals.
Compared with short-acting sulfonylureas—a common treatment for type 2 diabetes—long-acting sulfonylureas have a higher risk of low blood glucose. Then, are you forgetful or losing concentration at times? Find out how high blood glucose can affect your thinking.
What to know and do to prepare for your diabetes care during a weather emergency or other disruption.
The first study we’ll discuss looks at some of the challenges to taking medication as directed. The second is an update of blood pressure management recommendations for people with diabetes.
In today’s busy world, information can come at you from so many sources—news reports, social media, magazine articles. And advertisements. When it comes to ads for drugs and other medical products, here’s what to know about reliable information, what can you trust, and why.
Brand-new information shared at the American Diabetes Association’s recent Scientific Sessions about SGLT2-inhibitors and unprecedented protection for the heart. And a study that investigated whether monitoring blood glucose makes a difference in type 2 diabetes.
The final episode of our series about type 2 diabetes medications focuses on an injectable medication that’s been around the longest—since the early 1920s in fact. That medication is insulin, available today in various formulations that are used once daily or multiple times a day, depending on what your body needs.
The second episode of our series about type 2 diabetes medications features prescription drugs that can be used when a single medication isn’t enough to keep blood glucose levels on target. Find out how well DDP-4 inhibitors, GLP-1 receptor agonists, and SGLT-2 inhibitors work at lowering A1C, 2) their risk of hypoglycemia, 3) effects on weight, 4) cost, 5) possible side effects, and 6) heart protection.
This is the first installment of a three-part series about type 2 diabetes medications. There are nine classes of diabetes drugs that, along with healthy eating, weight management, and physical activity, help you achieve on-target blood glucose levels. Today we'll look at some of the usual "starter" or beginning medications, including metformin.
Listeners, you are probably aware of the two main types of diabetes, type 1 (an autoimmune disorder) and type 2 (a metabolic disorder). Today we’re going to talk about two types of diabetes that aren't as well known. LADA (Latent Autoimmune Diabetes in Adults) is a subgroup of type 1 that's tricky to diagnose and sometimes challenging to manage. And gestational diabetes affects between 3 and 9 percent of pregnant women, but can usually be managed with diet, exercise, and some oral medications.
We have two studies for you about hypoglycemia, or low blood glucose. As you know, hypoglycemia is a risk with certain diabetes medications and something that&'s important to manage to stay safe. We'll look at a study that examines the risk of hypoglycemia in people with type 2 diabetes on different medications, as well as an analysis of hospitalizations for hypoglycemia in patients with type 1.
Happy New Year, listeners! Let's talk about ways you can prepare for a year of your best health—from making doctor's appointments and seeking out diabetes education to renewing your prescriptions and building your support network. Find out about all this and more.
Your feedback is valuable to us. Should you encounter any bugs, glitches, lack of functionality or other problems, please email us on [email protected] or join Moon.FM Telegram Group where you can talk directly to the dev team who are happy to answer any queries.